FDA Commissioner Marty Makary’s pledge to reexamine the safety of medication abortion isn’t just pointless — it’s dangerous.

Food and Drug Administration Commissioner Marty Makary said he plans to review the safety of abortion drug mifepristone after a recent study raised concerns about medical side effects.

HHS Secretary Robert F. Kennedy Jr. asked the FDA "to review the latest data on mifepristone​," but experts say concerns ...

Three years after the Dobbs decision, the legal challenges continue for activists on both sides of the abortion debate.

This story was originally reported by Shefali Luthra of The 19th. Meet Shefali and read more of her reporting on gender, ...

In 2022 alone, chemical abortions accounted for 63% of all abortions in the United States, totaling 642,700 . Shockingly, ...

Food and Drug Administration (FDA) Commissioner Marty Makary committed to reviewing the abortion drug mifepristone in a letter sent to Sen. Josh Hawley (R-Mo.). “As with all drugs, FDA continues ...

FDA chief Marty Makary just committed to me to do a full review of the chemical abortion drug’s safety: “As Commissioner of Food and Drugs, I am committed to conducting a review of ...

Sen. Josh Hawley, R-Mo., shared the contents of a letter he received from Food and Drug Administration Commissioner Marty Makary in an X post Monday. Makary’s letter came in response to a letter ...